Inherited disorders of epidermal keratinization

Journal of Dermatological Science

Volumn 18, Issue 3, 1998, Pages 139-154

  Ishida Yamamoto, Akemi ^a   Tanaka, Hiraku ^a   Nakane, Hiroshi ^a   Takahashi, Hidetoshi ^a   Iizuka, Hajime ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Ichthyosis; Keratinocytes; Palmoplantar keratoderma

Indexed keywords

CELL DIFFERENTIATION; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; EPIDERMIS; EXTRACELLULAR SPACE; GAUCHER DISEASE; GENETIC DISORDER; HEMIDESMOSOME; HUMAN; KERATINIZATION; KERATOSIS PALMOPLANTARIS; MEMBRANE BINDING; PRIORITY JOURNAL; REFSUM DISEASE; REVIEW; SJOEGREN LARSSON SYNDROME; SKIN DISEASE; TRICHOTHIODYSTROPHY;

EPIDERMIS; HUMANS; ICHTHYOSIS; KERATINS; KERATODERMA, PALMOPLANTAR; KERATOSIS;

EID: 0032403911     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(98)00041-3     Document Type: Review

References (111)

1. [1] Elias PM, Brown BE, Fritsch P, Goerke J, Gray M, White RJ. Localization and composition of lipids in neonatal mouse stratum granulosum and stratum corneum. J Invest Dermatol 1979;73:339-48.
2. [2] Ishida-Yamamoto A, Iizuka H. Structural organization of cornified cell envelopes and alterations in inherited skin disorders. Exp Dermatol 1998;7:1-10.
3. [3] Ishida-Yamamoto A, Takahashi H, Presland RB, Dale BA, Iizuka H. Translocalion of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma. Lab Invest 1998;in press.
4. [4] Fuchs E. Epidermal differentiation: the bare essentials. J Cell Biol 1990;111:2807-14.
5. [5] Manabe M, Mizoguchi M, Suto H, Ogawa H. Epidermal structural proteins in skin disorders. J Dermatol Sci 1997;15:143-65.
6. [6] Fuchs E. Genetic disorders of keratins and their associated proteins. J Dermatol Sci 1996;13:181-92.
7. [7] Albers KM. Keratin biochemistry. Clin Dermatol 1996;14:309-20.
8. [8] Corden LD, McLean WHI. Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp Dermatol 1996;5:297-307.
9. [9] Bale SJ, DiGiovanna J. Genetic approaches to understanding the keratinopathies. Adv Dermatol 1997;12:99-113.
10. [10] Candi E, Tarsca E, Digiovanna JJ, Compton JG, Elias PM, Marekov LN, Steinert PM. A highly conserved lysine residue on the head domain of type II keratins is essential for the attachment of keratin intermediate filaments to the cornified cell envelope through isopeptide crosslinking by transglutaminase. Proc Natl Acad Sci USA 1998;95:2067-72.
11. [11] Dale BA, Resing KA, Presland RB. Keratohyalin granule proteins. In: Leigh IM, Lane EB, Watt FM, editors. The Keratinocyte Handbook. Cambridge: Cambridge University Press, 1994:323-350.
12. [12] Dale BA, Nirunsuksiri W, Rehemtulla A, Lewis RSP, Presland RB. Profilaggrin is proteolytically cleaved by furin during epidermal differentiation. J Invest Dermatol 1997;108:554.
13. [13] Presland RB, Kimball JR, Kautsky MB, Lewis SP, Lo CY, Dale BA. Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation. J Invest Dermatol 1997;108:170-8.
14. [14] Steinert PM, Marekov LN. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 1995;270:17702-11.
15. [15] Kim S-Y, Chung S-I, Steinert PM. Highly active soluble processed forms of the transglutaminase 1 enzyme in epidermal keratinocytes. J Biol Chem 1995;270:18026-35.
16. [16] Steinert PM, Kim S-Y, Chung S-I, Marekov LN. The transglutaminase 1 enzyme is variably acylated by myristate and palmitate during differentiation in epidermal keratinocytes. J Biol Chem 1996;271:26242-50.
17. [17] Steinert PM, Chung S-I, Kim S-Y. Inactive zymogen and highly active proteolytically processed membrane-bound forms of the transglutaminase 1 enzyme in human epidermal keratinocytes. Biochem Biophys Res Comm 1996;221:101-6.
18. [18] Steinert PM, Kartasova T, Marekov LN. Biochemical evidence that small proline-rich proteins and trichohyalin function in epithelia by modulation of the biomechanical properties of their cornfied cell envelopes. J Biol Chem 1998;273:11758-69.
19. [19] Jarnik M, Simon MN, Steven AC. Cornified cell envelope assembly: a model based on electron microscopic determinations of thickness and projected density. J Cell Sci 1998;111:1051-60.
20. [20] Wertz PW, Madison KC, Downing DT. Covalently bound lipids of human stratum corneum. J Invest Dermatol 1989;92:109-11.
21. [21] Roop D. Defects in the barrier. Science 1995;267:474-5.
22. [22] Frost P, Van Scott EJ. Ichthyosiform dermatoses. Classification based on anatomic and biometric observations. Arch Dermatol 1966;94:113-26.
23. [23] Frost P, Weinstein GD, Van Scott EJ. The ichthyosiform dermatoses II. Autoradiographic studies of epidermal proliferation. J Invest Dermatol 1966;47:561-7.
24. [24] Nirunsuksiri W, Zhang S-H, Fleckman P. Reduced stability and bi-allelic, coequal expression of profilaggrin mRNA in keratinocytes cultured from subjects with ichthyosis vulgaris. J Invest Dermatol 1998;110:854-61.
25. [25] Sybert VP, Dale BA, Holbrook KA. Ichthyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol 1985;84:191-4.
26. [26] Shapiro LJ, Yen P, Pomerantz D, Martin E, Rolewic L, Mohandas T. Molecular studies of deletions at the human steroid sulfatase locus. Proc Natl Acad Sci USA 1989;86:8477-81.
27. [27] Basler E, Grompe M, Parenti G, Yates J, Ballabio A. Identification of point mutations in the steroid sulfatase gene of three patients with X-linked ichthyosis. Am J Hum Genet 1992;50:483-91.
28. [28] Alperin ES, Shapiro LJ. Characterization of point mutations in patients with X-linked ichthyosis. Effects on the structure and functions of the steroid sulfatase protein. J Biol Chem 1997;272:20756-63.
29. [29] Morita E, Katoh O, Shinoda S, Hiragun T, Tanaka T, Kameyoshi Y, Yamamoto S. A novel point mutation in the steroid sulfatase gene in X-linked ichthyosis. J Invest Dermatol 1997;109:244-5.
30. [30] Maloney ME, Williams ML, Epstein EH Jr., Law MYL, Fritsch PO, Elias PM. Lipids in the pathogenesis of ichthyosis: topical cholesterol sulfate-induced scaling in hairless mice. J Invest Dermatol 1984;83:252-6.
31. [31] Elias PM, Williams ML, Maloney ME, Bonifas JA, Brown BE, Grayson S, Epstein EH Jr. Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis. J Clin Invest 1984;74:1414-21.
32. [32] Rehfeld SJ, Plachy WZ, Williams ML, Elias PM. Calorimetric and electron spin resonance examination of lipid phase transitions in human stratum corneum: molecular basis for normal cohesion and abnormal desquamation in recessive X-linked ichthyosis. J Invest Dermatol 1988;91:499-505.
33. [33] Williams ML, Rutherford SL, Feingold KR. Effects of cholesterol sulfate on lipid methabolism in cultured human keratinocyts and fibroblasts. J Lipid Res 1987;28:955-67.
34. [34] Traupe H, Kolde G, Happle R. Autosomal dominant lamellar ichthyosis: a new skin disorder. Clin Genet 1984:26:457-61.
35. [35] Anton-Lamprecht I. The skin. In: Papadimitriou JM, Henderson DW, Spagnolo DV, editors. Diagnostic Ultrastructure of Non-Neoplasmic Diseases. Edinburgh: Churchill Livingstone, 1992:459-550.
36. [36] Russell LJ, DiGiovanna JJ, Rogers GR, Steinert PM, Hashem N, Compton JG, Bale SJ. Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nat Genet 1995;9:279-83.
37. [37] Huber M, Rettler I, Bernasconi K, Frenk E, Lavrijsen SPM, Ponec M, Bon A, Lautenschlager S, Schorderet DF, Hohl D. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 1995;267:525-8.
38. [38] Hennies HC, Küster W, Wiebe V, Krebsová A, Reis A. Genotype/phenotype correlation in autosomal recessive lamellar ichthyosis. Am J Hum Genet 1998;62:1052-61.
39. [39] Laiho E, Ignatius J, Mikkola H, Yee VC, Teller DC, Niemi K-M, Saarialho-Kere U, Kere J, Palotie A. Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population. Am J Hum Genet 1997;61:529-38.
40. [40] Huber M, Rettler I, Bernasconi K, Wyss M, Hohl D. Lamellar ichthyosis is genetically heterogeneous - cases with normal keratinocyte transglutaminase. J Invest Dermatol 1995;105:653-4.
41. [41] Bale SJ, Russell LJ, Lee ML, Compton JG, DiGiovanna JJ. Congenital recessive ichthyosis unlinked to loci for epidermal transglutaminases. J Invest Dermatol 1996;107:808-11.
42. [42] Parmentier L, Lakhdar H, Blanchet-Bardon C, Marchand S, Dubertret L, Weissenbach J. Mapping of a second locus for lamellar ichthyosis to chromosome 2q33-35. Hum Mol Genet 1996;5:555-9.
43. [43] Huber M, Yee VC, Burri N, Vikerfors E, Lavrijsen APM, Paller AS, Hohl D. Consequences of seven novel mutations on the expression and structure of keratinocyte transglutaminase. J Biol Chem 1997;272:21018-26.
44. [44] Candi E, Melino G, Lahm A, Ceci R, Rossi A, Kim IG, Ciani B, Steinert PM. Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processing. J Biol Chem 1998;273:13693-702.
45. [45] Jeon S, Djian P, Green H. Inability of keratinocytes lacking their specific transglutaminase to form cross-linked envelopes: absence of envelopes as a simple diagnostic test for lamellar ichthyosis. Proc Natl Acad Sci USA 1998;95:687-90.
46. [46] Matsuki M, Yamashita F, Ishida-Yamamoto A, Yamad K, Kinoshita C, Fushiki S, Ueda E, Morishima Y, Tabata K, Yasuno H, Hashida M, Iizuka H, Ikawa M, Okabe M, Kondoh G, Kinoshita T, Takeda J, Yamanishi K. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci 1998;95:1044-9.
47. [47] Proksch E, Feingold KR, Mao-Qiang M, Elias PM. Barrier function regulates epidermal DNA synthesis. J Clin Invest 1991;87:1668-73.
48. [48] Sahn EE, Weimer CE Jr., Garen PD. Annular epidermolytic ichthyosis: a unique phenotype. J Am Acad Dermatol 1992;27:348-55.
49. [49] Joh G-Y, Traupe H, Metze D, Nashan D, Huber M, Hohl D, Longley MA, Rothnagel JA, Roop DR. A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma. J Invest Dermatol 1997;108:357-61.
50. [50] Fuchs E, Esteves RA, Coulombe PA. Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc Natl Acad Sci USA 1992;89:6906-10.
51. [51] Bickenbach JR, Longley MA, Bundman DS, Dominey AM, Bowden PE, Rothnagel JA, Roop DR. A transgenic mouse model that recapituates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis. Differentiation 1996;61:129-39.
52. [52] Porter RM, Reichelt J, Lunny DP, Magin TM, Lane EB. The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE. J Invest Dermatol 1998;110:951-7.
53. [53] Ishida-Yamamoto A, McGrath JA, Judge MR, Leigh IM, Lane EB, Eady RAJ. Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma). J Invest Dermatol 1992;99:19-26.
54. [54] Ishida-Yamamoto A, Eady RAJ, Underwood RA, Dale BA, Holbrook KA. Filaggrin expression in epidermolytic ichthyosis (epidermolytic hyperkeratosis). Br J Dermatol 1994;131:767-79.
55. [55] Fisher LB, Wells GC. The mitotic rate and duration in lesions of psoriasis and ichthyosis. Br J Dermatol 1968;80:235-40.
56. [56] Kanitakis J, Hoyo E, Chouvet B, Thivolet J, Faure M, Claudy A. Keratinocyte proliferation in epidermal keratinocyte disorders evaluated through PCNA/cyclin immunolabelling and AgNOR counting. Acta Derm Venereol 1993;73:370-5.
57. [57] Bonifas JM, Bare JW, Chen MA, Ranki A, Niemi K-M, Epstein EH Jr. Evidence against keratin gene mutations in a family with ichthyosis hystrix Curth-Macklin. J Invest Dermatol 1993;101:890-1.
58. [58] Dale BA, Kam E. Harlequin Ichthyosis. Variability in expression and hypothesis for disease mechanism. Arch Dermatol 1993;129:1471-7.
59. [59] Kam E, Nirunsuksiri W, Hager B, Fleckman P, Dale BA. Protein phosphatase activity in human keratinocytes cultured from normal epidermis and epidermis from patients with harlequin ichthyosis. Br J Dermatol 1997;137:874-82.
60. [60] Ishida-Yamamoto A, McGrath JA, Lam H, Iizuka H, Friedman RA, Christiano AM. The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope. Am J Hum Genet 1997;61:581-9.
61. [61] Maestrini E, Monaco AP, McGrath JA, Ishida-Yamamoto A, Camisa C, Hovnanian A, Weeks DE, Lathrop M, Uitto J, Christiano AM. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet 1996;13:70-7.
62. [62] Korge BP, Ishida-Yamamoto A, Pünter C, Dopping-Hepenstal PJC, Iizuka H, Stephenson AM, Eady RAJ, Munro CS. Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis. J Invest Dermatol 1997;109:604-10.
63. [63] Ishida-Yamamoto A, Takahashi H, Iizuka H. Loricrin and human skin disease: molecular basis of loricrin kratodermas. Histol Histopath 1998;13:819-26.
64. [64] de Viragh PA, Scharer L, Bundman D, Roop DR. Loricrin deficient mice: upregulation of other cell envelope precursors rescues the neonatal defect but fails to restore epidermal barrier function. J Invest Dermatol 1997;108:555.
65. [65] Richard G, Lin J-P, Smith L, Whyte YM, Itin P, Wollina U, Epstein E Jr., Hohl D, Giroux J-M, Charnas L, Bale SJ, DiGiovanna JJ. Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity, and analysis of candidate genes. J Invest Dermatol 1997;109:666-71.
66. [66] De Laurenzi V, Rogers GR, Hamrock DJ, Marekov LN, Steinert PM, Compton JG, Markova N, Rizzo WB. Sjogren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat Genet 1996;12:52-7.
67. [67] Mihalik SJ, Morrell JC, Kim D, Sacksteder KA, Watkins PA, Gould SJ. Identificatin of PAHX, a Refsum disease gene. Nat Genet 1997;17:185-9.
68. [68] Jansen GA, Ofman R, Ferdinandusse S, Ijlst L, Muijsers AO, Skjeldal OH, Stokke O, Jakobs C, Besley GTN, Wraith JE, Wanders RJA. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat Genet 1997;17:190-3.
69. [69] Braverman N, Steel G, Obie C, Moser A, Moser H, Gould SJ, Valle D. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet 1997;15:369-76.
70. [70] Purdue PE, Zhang JW, Skoneczny M, Lazarow PB. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat Genet 1997;15:381-4.
71. [71] Motley AM, Hettema EH, Hogenhout EM, Brites P, ten Asbroek ALMA, Wijburg FA, Baas F, Heijmans HS, Tabak HF, Wanders RJA, Distel B. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nat Genet 1997;15:377-80.
72. [72] Kalter DC, Atherton DJ, Clayton PT. X-linked dominant Conradi-Hünermann syndrome presenting as congenital erythroderma. J Am Acad Dermatol 1989;21:248-56.
73. [73] Holmes RD, Wilson GN, Hajra AK. Peroxisomal enzyme deficiency in the Conradi-Hünermann form of chondrodysplasia puncttata. New Engl J Med 1987;316:1608.
74. [74] Emami S, Hanley KP, Esterly NB, Daniallinia N, Williams ML. X-linked dominant ichthyosis with peroxisomal deficiency. An ultrastructural and ultracytochemical study of the Conradi-Hünermann syndrome and its murine homologue, the bare patches mouse. Arch Dermatol 1994;130:325-36.
75. [75] Das S, Metzenberg A, Pai GS, Gitschier J. Mutational analysis of the biglycan gene excludes it as a candidate for X-linked dominant chondrodysplasia punctata, dyskeratosisi congenita, and incontinentia pigmenti. Am J Hum Genet 1994;54:922-5.
76. [76] Happle R. X-linked dominant chondrodysplasia punctata/ichthyosis/cataract syndrome in males. Am J Med Genet 1995;57:493.
77. [77] Fink-Puches R, Soyer HP, Pierer G, Kerl H, Happl R. Systematized inflammatory epidermal nevus with symmetrical involvement: an unusual case of CHILD syndrome? J Am Acad Dermatol 1997;36:823-6.
78. [78] Emami S, Rizzo WB, Hanley KP, Taylor JM, Goldyne ME, Williams ML. Peroxisomal abnormality in fibroblasts from involved skin of CHILD syndrome. Arch Dermatol 1992;128:1213-22.
79. [79] Igal RA, Coleman RA. Neutral lipid storage disease: a genetic disorder with abnormalities in the regulation of phopholipid metabolism. J Lipid Res 1998;39:31-43.
80. [80] Igal RA, Coleman RA. Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts. J Biol Chem 1996;271:16644-51.
81. [81] Elias PM, Williams ML. Neutral lipid storage disease with ichthyosis. Defective lamellar body contents and intracellular dispersion. Arch Dermatol 1985;121:1000-8.
82. [82] Schmidt B, Selmer T, Ingendoh A, von Figura K. A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency. Cell 1995;82:271-8.
83. [83] Dierks T, Schmidt B, von Figure K. Conversion of cysteine to formylglycine: a protein modification in the encoplasmic reticulum. Proc Natl Acad Sci USA 1997;94:11963-8.
84. [84] Itin PH, Pittelkow MR. Trichothiodystrophy: review of sulfur-deficient brittle hair syndromes and association with the ectodermal dysplasias. J Am Acad Dermatol 1990;22:705-17.
85. [85] Takayama K, Danks DM, Salazar EP, Cleaver JE, Weber CA. DNA repair characteristics and mutations in the ERCC2 DNA repair and transcription gene in a trichothiodystrophy patient. Hum Mutat 1997;9:519-25.
86. [86] Takayama K, Salazar EP, Broughton BC, Lehmann AR, Sarasin A, Thompson LH, Weber CA. Defects in the DNA repair and transcription gene ERCC2(XPD) in trichothiodystrophy. Am J Hum Genet 1996;58:263-70.
87. [87] Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Jaspers NGJ, Fawcett H, Harcourt SA, Arlett CF, Lehmann AR. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci USA 1997;94:8658-63.
88. [88] Broughton BC, Thompson AF, Harcourt SA, Vermeulan W, Hoeijmakers JHJ, Botta E, Stefanini M, King MD, Weber CA, Cole J, Arlett CF, Lehmann AR. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome. Am J Hum Genet 1995;56:167-74.
89. [89] Weeda G, Eveno E, Donker I, Vermeulen W, Chevallier-Lagente O, Taieb A, Stary A, Hoeijmakers JHJ, Mezzina M, Sarasin A. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy. Am J Hum Genet 1997;60:320-9.
90. [90] Hwang JR, Moncollin V, Vermeulen W, Seroz T, van Vuuren H, Hoeijmakers JHJ, Egly JM. A 3′→5′ XPB helicase defect in repair/transcription factor TFIIH of xeroderma pigmentosum group B affects both DNA repair and transcription. J Biol Chem 1996;271:15898-904.
91. [91] Stefanini M, Vermeulen W, Weeda G, Giliani S, Nardo T, Mezzina M, Sarasin A, Harper JI, Arlett CF, Hoeijmakers JHJ, Lehmann AR. A new nucleotide-excision-repair gene associated with the disorder trichothiodystrophy. Am J Hum Genet 1993;53:817-21.
92. [92] Beutler E. Gauchers disease. New Engl J Med 1991;7:1354-560.
93. [93] Holleran WM, Ginns EI, Menon GK, Grundmann J-U, Fartasch M, McKinney CE, Ellias PM, Sidransky E. Consequence of β-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 1994;93:1756-64.
94. [94] Fujimoto A, Tayebi N, Sidransky E. Congenital ichthyosis preceding neurologic symptoms in two sibs with type 2 Gaucher disease. Am J Med Genet 1995;59:356-8.
95. [95] Sidransky E, Sherer DM, Ginns EI. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr Res 1992;32:494-8.
96. [96] Holleran WM, Takagi Y, Imokawa G, Jackson S, Lee JM. Elias PM. β-Glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation. J Lipid Res 1992;33:1201-9.
97. [97] Marsh NL, Elias PM, Holleran WM. Glucosylceramides stimulate murine epidermal hyperproliferation. J Clin Invest 1995;95:2903-9.
98. [98] Imokawa G, Kuno H, Kawai M. Stratum corneum lipids serve as a bound-water modulator. J Invest Dermatol 1991;96:845-51.
99. [99] Kimonis V, DiGiovanna JJ, Yang J-M, Doyle SZ, Bale SJ, Compton JG. A mutation in the V1 end domain of keraitn 1 in non-epidermolytic palmar-plantar keratoderma. J Invest Dermatol 1994;103:764-9.
100. [100] Kobayashi S, Tanaka T, Matsuyoshi N, Imamura S. Keratin 9 point mutation in the pedigree of epidermolytic hereditary palmoplantar keratoderma perturbs keratin intermediate filament network formation. FEBS Lett 1996;386:149-55.
101. [101] Shamsher MK, Navsaria HA, Stevens HP, Ratnavel RC, Purkis PE, Kelsell DP, McLean WHI, Cook LJ, Griffiths WAD, Gschmeissner S, Spurr N, Leigh IM. Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Hum Mol Genet 1995;4:1875-81.
102. [102] McLean WHI, Smith FJD, van Goor H, Covello SP, Coleman CS, Uitto J, Jonkman MF. A new gene for pachyonychia congenita type 2: keratin K6b is the expression partner of K17 in epidermal appendages. J Invst Dermatol 1998;110:502.
103. [103] Vohwinkel H. Keratoma hereditarium mutilans. Arch Dermatol Syphilol 1929;158:354-64.
104. [104] Gibbs RC, Frank SB. Keratoma hereditaria mutilans (Vohwinkel). Arch Dermatol 1966;94:619-25.
105. [105] Sevior KB, Hatamochi A, Stewart IA, Bykhovskaya Y, Allen-Powell DR, Fischel-Ghodsian N, Maw MA. Mitochondorial A7445G mutation in two pedigrees with palmoplantar keratoderma and deafness. Am J Med Genet 1998;75:179-85.
106. [106] Risk JM, Field EA, Field JK, Whittaker J, Fryer A, Ellis A, Shaw JM, Friedmann PS, Bishop DT, Bodmer J, Leigh IM. Tylosis oesophageal cancer mapped. Nat Genet 1994;8:319-21.
107. [107] Stevens HP, Kelsell DP, Bryant SP, Bishop DT, Spurr NK, Weissenbach J, Marger D, Marger RS, Leigh IM. Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol 1996;132:640-51.
108. [108] Natt E, Kida K, Odievre M, Di Rocco M, Scherer G. Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II. Proc Natl Acad Sci USA 1992;89:9297-301.
109. [109] Tallab TM. Richner-Hanhar syndrome: importance of early diagnosis and early intervention. J Am Acad Dermatol 1996;35:857-9.
110. [110] Laass MW, Hennies HC, Preis S, Stevens HP, Jung M, Leigh IM, Wienker TF, Reis A. Localisation of a gene for Papillon-Lefèvre syndrome to chromosome 11q14-q21 by homozygosity mapping. Hum Genet 1997;101:376-82.
111. [111] Starfield M, Hennies HC, Jung M, Jenkins T, Wienker T, Hull P, Spurdle A, Küster W, Ramsay M, Reis A. Localization of the gene causing keratolytic winter erythema to chromosome 8p22-p23, and evidence for a founder effect in South African Afrikaans-speakers. Am J Hum Genet 1997;61:370-8.